Is Cyclo Therapeutics Inc (CYTH) a Good Choice in Drug Manufacturers

Cyclo Therapeutics Inc (CYTH) is around the top of the Drug Manufacturers - Specialty & Generic industry according to InvestorsObserver. CYTH received an overall rating of 72, which means that it scores higher than 72 percent of all stocks. Cyclo Therapeutics Inc also achieved a score of 93 in the Drug Manufacturers - Specialty & Generic industry, putting it above 93 percent of Drug Manufacturers - Specialty & Generic stocks. Drug Manufacturers - Specialty & Generic is ranked 108 out of the 148 industries.

CYTH has an Overall Score of 72. Find out what this means to you and get the rest of the rankings on CYTH!

See Full CYTH Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 72 means the stock is more attractive than 72 percent of stocks. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Cyclo Therapeutics Inc Stock Today?

Cyclo Therapeutics Inc (CYTH) stock is trading at $1.71 as of 12:02 PM on Wednesday, Feb 14, an increase of $0.13, or 8.23% from the previous closing price of $1.58. The stock has traded between $1.53 and $1.73 so far today. Volume today is less active than usual. So far 40,365 shares have traded compared to average volume of 90,824 shares. Click Here to get the full Stock Report for Cyclo Therapeutics Inc stock.